Kamardin L N, Romanchishen A F
Vopr Onkol. 1990;36(3):342-6.
Concomitant pathology of the thyroid was established in 244 out of 533 (45.8%) patients with primary cancer of the organ. The latter group are main contributors to the increase in thyroid cancer incidence. Slow progression and low frequency of metastatic dissemination of cancer concomitant to other thyroid pathology suggest an inhibiting effect of benign tumors, toxic goiter and autoimmune thyroiditis on growth and dissemination of cancer which is, in turn, attributed to autosensitization to unaltered thyroid antigens. In regions nonendemic for goiter, examination and surgical treatment of nodular lesions of the thyroid should be carried out in specialized surgical clinics to prevent cancer or to assure treatment at early stages of the disease. Since solitary carcinomas are extremely likely to disseminate, surgery should be supplemented with regional lymph node biopsy involving intraoperative chromothyrolymphography.
在533例原发性甲状腺癌患者中,有244例(45.8%)发现有甲状腺伴发病变。后一组是甲状腺癌发病率增加的主要因素。与其他甲状腺病变并存的癌症进展缓慢且转移扩散频率低,提示良性肿瘤、毒性甲状腺肿和自身免疫性甲状腺炎对癌症的生长和扩散具有抑制作用,这反过来又归因于对未改变的甲状腺抗原的自身致敏。在非地方性甲状腺肿流行地区,应在专业外科诊所对甲状腺结节性病变进行检查和手术治疗,以预防癌症或确保疾病早期得到治疗。由于孤立性癌极易扩散,手术应辅以区域淋巴结活检,包括术中染色甲状腺淋巴管造影。